Search

everythinglearnresearchcommunity

for

Search:↓

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Prenatal and postnatal environments both affect PCOS development and gut microbiota in mice.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Lower vitamin D levels may contribute to female hair loss.

Liangxue Zhituo prescription effectively treats androgenic alopecia with no serious side effects.

Men with androgenetic alopecia do not have elevated DHEA-S levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

The cream-mask and gel-mask with certain plant extracts improved hair growth in rats similar to a common hair growth treatment.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Androgenetic alopecia patients have a higher risk of metabolic syndrome.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

The spironolactone cream did not reduce hair growth in women with hirsutism.

Spironolactone did not make hair thinner in women with excess hair growth.

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

DHT, not testosterone, mainly affects hair growth and related conditions.

Topical minoxidil effectively treats Female Pattern Hair Loss in women of all ages and hormone levels, but evidence for antiandrogens is limited.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.